MDNCOTCSurgical & Medical Instruments & ApparatusFiscal year ends February 28
Medinotec Inc.
Financials through Q2 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$5.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $58.78M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q3 FY2023 Ended Nov 30, 2022 | Jan 19, 2023 | During market hours | – | – | – |
Press releases
Announcements Medinotec filed with the SEC
NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS AND PROXY STATEMENT
Regulation FD disclosure · EX-99.1 to Form 8-K
Notice of 2023 Annual Meeting of Stockholders
Regulation FD disclosure · EX-99.1 to Form 8-K
2. PURPOSE, COMPOSITION AND MEETINGS OF THE COMMITTEE
Auditor change · Other events · EX-99.1 to Form 8-K
CFO Pieter van Niekerk joined Natalie Stoberman from the Proactive studio to discuss how the company's reach in niche medical device manufacturing
Regulation FD disclosure · EX-99.1 to Form 8-K
Markets Group Welcomes Medinotec Inc. to OTCQX
Regulation FD disclosure · EX-99.1 to Form 8-K
of an Over-the-Counter Quoting and Trading Symbol (MDNC) for the Common Stock of Medinotec Inc.
Regulation FD disclosure · EX-99.1 to Form 8-K
Main Ring Road, Delhi – 110052
Results of operations · EX-99.1 to Form 8-K
MEDINOTEC –Progress Made Towards Quotation On The OTCQX
Results of operations · EX-99.1 to Form 8-K